These medications help calm the overactive brain signals that cause involuntary movements
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/cbe1db18-ec4e-4ffa-927f-14c00e2892ea/doctor-medication-1342134422)
Healthcare provider, with bottles of prescription medication, discussing them with a patient in office
Twitching. Thrusting. Shaking. Grimacing.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The involuntary movements associated with tardive dyskinesia (TD) can be frustrating, embarrassing and downright debilitating. In some people, they’re so mild that they’re mostly unnoticeable. But for others, these movements are so severe that they can affect your ability to perform everyday activities and live life the way you want.
Could a VMAT2 inhibitor reduce your symptoms? Movement disorders neurologist Adam Margolius, MD, explains what VMAT2 inhibitors are and how these medications may be able to help.
VMAT2 inhibitors are medications that can make involuntary movements from tardive dyskinesia less severe. They help calm the overactive brain signals that are thought to cause TD symptoms.
“These medications can be quite effective in lessening TD-related movements,” Dr. Margolius says. “While they don’t eliminate symptoms completely, they can significantly reduce movements and improve your quality of life.”
But let’s back up. To understand how VMAT2 inhibitors can help, it’s important to understand the basics of TD itself.
Tardive dyskinesia is a movement disorder that’s most often the result of taking medication to block dopamine (known as dopamine antagonists). Researchers think that, in some people, blocking this neurotransmitter can cause the brain’s dopamine receptors to become extra sensitive. And that can affect the brain’s movement-control circuits, leading to the involuntary movements that come with tardive dyskinesia.
Advertisement
But VMAT2 inhibitors reduce the amount of dopamine that gets released between your nerve cells. And that can help calm TD symptoms.
The U.S. Food and Drug Administration (FDA) has approved two VMAT2 inhibitors for tardive dyskinesia: deutetrabenazine (sold as Austedo® or Austedo XR®) and valbenazine (brand name Ingrezza®).
They’re similar medications that work in slightly different ways to target and block a specific cellular protein called vesicular monoamine transporter 2 (aka VMAT2).
“Both medicines work well for most people with tardive dyskinesia, so it’s often a matter of which one is more accessible and affordable for each person,” Dr. Margolius notes.
Another VMAT2 inhibitor, tetrabenazine, used to be more commonly prescribed for tardive dyskinesia. But the FDA hasn’t approved it as an official treatment for this condition, so providers are much more likely to turn to deutetrabenazine and valbenazine.
Not everyone with tardive dyskinesia needs to take a VMAT2 inhibitor.
“It depends on whether the movements bother you and affect your ability to participate in normal activities and everyday life,” Dr. Margolius says.
Before your provider recommends a VMAT2 inhibitor for tardive dyskinesia, they’ll want to do a few other things:
VMAT2 inhibitors aren’t a good fit for everyone. Your provider may want to steer clear if you’re taking certain types of medications, or if you have or are at high risk for:
Advertisement
When you start a VMAT2 inhibitor, your healthcare provider will want to monitor you on an ongoing basis to see how well it’s working. This will help them decide whether to adjust your dosage or change your treatment.
They’ll use a 12-item assessment called the Abnormal Involuntary Movement Scale (AIMS) to evaluate the severity of tardive dyskinesia-related movements in your face, torso, arms and legs. But that’s not the only thing they consider.
“We’re also interested in your own perception of how the medicine is working for you,” Dr. Margolius says. “If you feel that it’s helping you and has improved your quality of life, that matters just as much as what AIMS tells us — and maybe even more.”
He adds that the opposite is true, too: If your TD movements look about the same as they did before but you say you feel worse, that’s also an important factor for your provider to consider.
VMAT2 inhibitors won’t cure tardive dyskinesia, but they can go a long way toward helping reduce the severity of symptoms. And Dr. Margolius says that sometimes the biggest barrier to starting these medications is simply knowing they exist.
“These treatments are relatively new within the last decade, so not everyone is aware of them,” he notes. “In my experience, a lot of people with this condition don’t even realize that treatment is available. But we definitely have options.”
Advertisement
Advertisement
Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more.
Learn more about our editorial process.
Advertisement
There’s no strong evidence that vitamin B, vitamin E and ginkgo biloba will reduce TD symptoms — but they’re safe to try
Healthy habits and a comfortable daily routine may make your TD symptoms more manageable
These neurological conditions affect muscle movement in separate ways
Stress doesn’t cause kidney stones, but your coping mechanisms might
Turning your head to the side and pulling your ear up and back is one common method for relief
Unexpected DNA changes can cause cells to grow out of control and lead to cancer
No, we aren’t all born with cancer cells — and having cancer in your family doesn’t mean you already have cancer or will necessarily develop it
Both can cause bleeding, irritation and pain, but you shouldn’t try to tell them apart on your own
Research hints at improved strength, balance, blood flow and weight loss, but more evidence is needed
The blended oat beverage may help curb hunger, but it doesn’t work like a GLP-1
Teen cycles are often ‘off-cycle’ for the first few years